Forte Biosciences (FBRX) Tax Rate (2018 - 2026)
Forte Biosciences (FBRX) reported Tax Rate of 1.71% for Q1 2026, down 76.05% quarter-over-quarter from 0.97% in Q4 2018.
Forte Biosciences (FBRX) Tax Rate (2018 - 2026) Analysis & Trends
Forte Biosciences (FBRX) has 2 years of Tax Rate data on file, last reported at 1.71% in Q1 2026.
- Tax Rate for Q1 2026 came in at 1.71%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 2.81% (up 829.0% YoY), and the FY2025 annual result was 25.01%, changed N/A from the prior year.
- Tax Rate eased to 1.71% in Q1 2026 per FBRX's latest filing, from 0.97% in the prior quarter.
- Over five years, Tax Rate peaked at 1.71% in Q1 2026 and troughed at 1.71% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -57.14 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -6.79 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 5.61 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.68 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | -1.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.71% |
| Mar 31, 2026 | -1.71% |
| Dec 31, 2018 | -0.97% |
| Dec 31, 2018 | -0.97% |
| Sep 30, 2018 | 134.01% |
| Sep 30, 2018 | 134.01% |